Li-Chen Yen

728 total citations
37 papers, 554 citations indexed

About

Li-Chen Yen is a scholar working on Infectious Diseases, Oncology and Molecular Biology. According to data from OpenAlex, Li-Chen Yen has authored 37 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Li-Chen Yen's work include Mosquito-borne diseases and control (7 papers), Colorectal Cancer Treatments and Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Li-Chen Yen is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Colorectal Cancer Treatments and Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Li-Chen Yen collaborates with scholars based in Taiwan, Japan and United States. Li-Chen Yen's co-authors include Shiu‐Ru Lin, Jaw‐Yuan Wang, Chien-Yu Lu, Ching‐Len Liao, Hwei‐Ming Wang, Ming‐Yii Huang, Deng‐Chyang Wu, Yih‐Huei Uen, I‐Chen Wu and Fang‐Jung Yu and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Li-Chen Yen

37 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li-Chen Yen Taiwan 14 247 185 165 80 74 37 554
Tammey Naab United States 14 253 1.0× 264 1.4× 211 1.3× 30 0.4× 113 1.5× 56 697
Simon J. Johnston United Kingdom 14 286 1.2× 214 1.2× 182 1.1× 19 0.2× 67 0.9× 29 592
Mona S. Abdellateif Egypt 12 159 0.6× 105 0.6× 141 0.9× 52 0.7× 42 0.6× 48 418
Mengying Tong China 16 165 0.7× 117 0.6× 269 1.6× 27 0.3× 46 0.6× 34 781
Monique Albert Canada 15 87 0.4× 174 0.9× 320 1.9× 50 0.6× 38 0.5× 22 632
Jiguang Li China 14 205 0.8× 175 0.9× 219 1.3× 18 0.2× 79 1.1× 36 604
Arun Khattri United States 14 282 1.1× 80 0.4× 188 1.1× 74 0.9× 34 0.5× 42 628
Jinli Wei China 12 118 0.5× 209 1.1× 269 1.6× 112 1.4× 32 0.4× 25 559
Jianqiang Liu China 7 261 1.1× 282 1.5× 461 2.8× 41 0.5× 55 0.7× 25 679

Countries citing papers authored by Li-Chen Yen

Since Specialization
Citations

This map shows the geographic impact of Li-Chen Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Chen Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Chen Yen more than expected).

Fields of papers citing papers by Li-Chen Yen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Chen Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Chen Yen. The network helps show where Li-Chen Yen may publish in the future.

Co-authorship network of co-authors of Li-Chen Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Li-Chen Yen. A scholar is included among the top collaborators of Li-Chen Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-Chen Yen. Li-Chen Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yen, Li-Chen, et al.. (2024). Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens. Frontiers in Immunology. 15. 1340645–1340645. 1 indexed citations
3.
Yen, Li-Chen, Hsin–Wei Chen, Chang-Chi Lin, et al.. (2023). Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement. Journal of Biomedical Science. 30(1). 41–41. 6 indexed citations
4.
Wang, Yung-Chih, Li-Chen Yen, Yao‐Wen Chang, et al.. (2023). SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19. Infection. 52(3). 955–983. 9 indexed citations
5.
Liu, Yichun, Li-Chen Yen, Fang‐Yih Liaw, et al.. (2021). Gender Differences in the Extended Theory of Planned Behaviour on Smoking Cessation Intention in Young Soldiers. International Journal of Environmental Research and Public Health. 18(15). 7834–7834. 3 indexed citations
6.
Kao, Chi‐Wen, et al.. (2021). Government’s subsidisation policy and utilisation of smoking cessation treatments: a population-based cross-sectional study in Taiwan. BMJ Open. 11(1). e040424–e040424. 1 indexed citations
7.
Lin, Ren-Jye, Ping‐Cheng Liu, Yu‐Ling Huang, et al.. (2020). Zinc finger protein ZFP36L1 inhibits influenza A virus through translational repression by targeting HA, M and NS RNA transcripts. Nucleic Acids Research. 48(13). 7371–7384. 17 indexed citations
8.
Liang, Shuyi, Shuting Liu, Li‐Chun Huang, et al.. (2019). <p>The antitumor properties of metformin and phenformin reflect their ability to inhibit the actions of differentiated embryo chondrocyte 1</p>. Cancer Management and Research. Volume 11. 6567–6579. 6 indexed citations
9.
Chen, Guang‐Wu, Ren-Jye Lin, Li-Chen Yen, et al.. (2019). Naturally occurring mutations in PB1 affect influenza A virus replication fidelity, virulence, and adaptability. Journal of Biomedical Science. 26(1). 55–55. 19 indexed citations
10.
Huang, Shih‐Ming, Ching‐Len Liao, An‐Rong Lee, et al.. (2019). Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection. Antimicrobial Agents and Chemotherapy. 64(1). 11 indexed citations
11.
Huang, Yiting, et al.. (2015). Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges. Journal of Biomedical Science. 22(1). 74–74. 18 indexed citations
12.
Huang, Ming‐Yii, et al.. (2014). Decreasing relapse in colorectal cancer patients treated with cetuximab by using the activating KRAS detection chip. Tumor Biology. 35(10). 9639–9647. 1 indexed citations
13.
Yen, Li-Chen, et al.. (2012). Multiple mRNA markers for the detection of circulating tumor cells in breast cancer patients. 4(1-2). 34–37. 1 indexed citations
15.
Shi, Hon‐Yi, et al.. (2011). Two-year quality of life after breast cancer surgery: A comparison of three surgical procedures. European Journal of Surgical Oncology. 37(8). 695–702. 40 indexed citations
16.
Yen, Li-Chen, Yih‐Huei Uen, Deng‐Chyang Wu, et al.. (2010). Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab. Annals of Surgery. 251(2). 254–260. 77 indexed citations
17.
Hsu, Chi‐Kuei, Li-Chen Yen, Der‐An Tsao, et al.. (2009). The KRAS Mutation is Highly Correlated With EGFR Alterations in Patients With Non-small Cell Lung Cancer. 1(2). 65–71. 4 indexed citations
18.
Chiu, Hua‐Hsien, Hwei‐Ming Wang, Li-Chen Yen, et al.. (2009). Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method. Annals of Surgical Oncology. 17(2). 624–633. 39 indexed citations
20.
Chou, Wei‐Yuan, et al.. (2008). Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1. The International Journal of Biochemistry & Cell Biology. 40(9). 1826–1834. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026